Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy - Aichler, Michaela; Ott, Katja (OncoTarget, 2014)